Cancer: Limitations of therapies exposed

Casanovas i Casanovas, Oriol

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/171689

Full metadata record

DC Field	Value	Language
dc.contributor.author	Casanovas i Casanovas, Oriol	-
dc.date.accessioned	2020-11-02T09:44:09Z	-
dc.date.available	2020-11-02T09:44:09Z	-
dc.date.issued	2012-04-01	-
dc.identifier.uri	https://hdl.handle.net/2445/171689	-
dc.description.abstract	Anti-angiogenic drugs, used for cancer treatment, target blood-vessel formation in tumours. Two studies commented here show that such drugs can reduce the efficiency of other anticancer agents and increase the aggressiveness of tumours.	-
dc.format.extent	6 p.	-
dc.format.mimetype	application/pdf	-
dc.language.iso	eng	-
dc.publisher	Springer Science and Business Media LLC	-
dc.relation.isformatof	Versió postprint del document publicat a: https://doi.org/10.1038/484044a	-
dc.relation.ispartof	Nature, 2012, vol. 484, issue. 7392, p. 44-46	-
dc.relation.uri	https://doi.org/10.1038/484044a	-
dc.rights	(c) Springer Science and Business Media LLC, 2012	-
dc.source	Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))	-
dc.subject.classification	Angiogènesi	-
dc.subject.classification	Medicaments antineoplàstics	-
dc.subject.classification	Tumors	-
dc.subject.other	Neovascularization	-
dc.subject.other	Antineoplastic agents	-
dc.title	Cancer: Limitations of therapies exposed	-
dc.type	info:eu-repo/semantics/article	-
dc.type	info:eu-repo/semantics/acceptedVersion	-
dc.date.updated	2020-10-29T15:04:25Z	-
dc.relation.projectID	info:eu-repo/grantAgreement/EC/FP7/281830/EU//STROMALIGN	-
dc.rights.accessRights	info:eu-repo/semantics/openAccess	-
Appears in Collections:	Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:

File	Description	Size	Format
Casanovas News&Views_v6_POST-PRINT.pdf		518.27 kB	Adobe PDF	View/Open

Show simple item record